Carnitine intake and excretion in neuromuscular disease

James Edwin Carroll, M. H. Brooke, J. B. Shumate, N. J. Janes

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Free and total carnitine serum concentrations and urinary excretion were examined in patients with various neuromuscular diseases. On a measured, low carnitine diet and during fasting, the patients did not differ from controls. Carnitine excretion in patients (3.08 ± 1.87 μmol/kg/day) and controls (2.99 ± 1.12) exceeded carnitine intake (patients, 2.35 ± 0.94 μmol/kg/day; controls 1.33 ± 0.70). Because of heterogeneity in the patient population, carnitine excretion was assessed according to creatinine excretion, chosen as an indicator of muscle mass. Those patients with daily creatinine excretion < 1 g/day had significantly lower carnitine excretion (106 ± 47 versus 205 ± 95 μmol/day, p<0.05), and there was a positive correlation between creatinine excretion and carnitine excretion (r=0.82) and between muscle carnitine and carnitine excretion (r=0.67). Urinary clearances for acylcarnitine were 10 to 20 times higher than those for free carnitine. Two patients with carnitine palmityl transferase deficiency were similar to the other patients, but the carnitine-deficient patient lost excessive carnitine during fasting, probably secondary to an elevated acylcarnitine fraction in the blood.

Original languageEnglish (US)
Pages (from-to)2693-2698
Number of pages6
JournalAmerican Journal of Clinical Nutrition
Volume34
Issue number12
StatePublished - Dec 1 1981
Externally publishedYes

Fingerprint

neuromuscular disorders
Neuromuscular Diseases
Carnitine
carnitine
excretion
creatinine
Creatinine
fasting
Fasting
Muscles
muscles
Transferases
blood serum
transferases

ASJC Scopus subject areas

  • Food Science
  • Medicine (miscellaneous)

Cite this

Carroll, J. E., Brooke, M. H., Shumate, J. B., & Janes, N. J. (1981). Carnitine intake and excretion in neuromuscular disease. American Journal of Clinical Nutrition, 34(12), 2693-2698.

Carnitine intake and excretion in neuromuscular disease. / Carroll, James Edwin; Brooke, M. H.; Shumate, J. B.; Janes, N. J.

In: American Journal of Clinical Nutrition, Vol. 34, No. 12, 01.12.1981, p. 2693-2698.

Research output: Contribution to journalArticle

Carroll, JE, Brooke, MH, Shumate, JB & Janes, NJ 1981, 'Carnitine intake and excretion in neuromuscular disease', American Journal of Clinical Nutrition, vol. 34, no. 12, pp. 2693-2698.
Carroll, James Edwin ; Brooke, M. H. ; Shumate, J. B. ; Janes, N. J. / Carnitine intake and excretion in neuromuscular disease. In: American Journal of Clinical Nutrition. 1981 ; Vol. 34, No. 12. pp. 2693-2698.
@article{476aa1280c5a4dfe9f107e9b331121c6,
title = "Carnitine intake and excretion in neuromuscular disease",
abstract = "Free and total carnitine serum concentrations and urinary excretion were examined in patients with various neuromuscular diseases. On a measured, low carnitine diet and during fasting, the patients did not differ from controls. Carnitine excretion in patients (3.08 ± 1.87 μmol/kg/day) and controls (2.99 ± 1.12) exceeded carnitine intake (patients, 2.35 ± 0.94 μmol/kg/day; controls 1.33 ± 0.70). Because of heterogeneity in the patient population, carnitine excretion was assessed according to creatinine excretion, chosen as an indicator of muscle mass. Those patients with daily creatinine excretion < 1 g/day had significantly lower carnitine excretion (106 ± 47 versus 205 ± 95 μmol/day, p<0.05), and there was a positive correlation between creatinine excretion and carnitine excretion (r=0.82) and between muscle carnitine and carnitine excretion (r=0.67). Urinary clearances for acylcarnitine were 10 to 20 times higher than those for free carnitine. Two patients with carnitine palmityl transferase deficiency were similar to the other patients, but the carnitine-deficient patient lost excessive carnitine during fasting, probably secondary to an elevated acylcarnitine fraction in the blood.",
author = "Carroll, {James Edwin} and Brooke, {M. H.} and Shumate, {J. B.} and Janes, {N. J.}",
year = "1981",
month = "12",
day = "1",
language = "English (US)",
volume = "34",
pages = "2693--2698",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "12",

}

TY - JOUR

T1 - Carnitine intake and excretion in neuromuscular disease

AU - Carroll, James Edwin

AU - Brooke, M. H.

AU - Shumate, J. B.

AU - Janes, N. J.

PY - 1981/12/1

Y1 - 1981/12/1

N2 - Free and total carnitine serum concentrations and urinary excretion were examined in patients with various neuromuscular diseases. On a measured, low carnitine diet and during fasting, the patients did not differ from controls. Carnitine excretion in patients (3.08 ± 1.87 μmol/kg/day) and controls (2.99 ± 1.12) exceeded carnitine intake (patients, 2.35 ± 0.94 μmol/kg/day; controls 1.33 ± 0.70). Because of heterogeneity in the patient population, carnitine excretion was assessed according to creatinine excretion, chosen as an indicator of muscle mass. Those patients with daily creatinine excretion < 1 g/day had significantly lower carnitine excretion (106 ± 47 versus 205 ± 95 μmol/day, p<0.05), and there was a positive correlation between creatinine excretion and carnitine excretion (r=0.82) and between muscle carnitine and carnitine excretion (r=0.67). Urinary clearances for acylcarnitine were 10 to 20 times higher than those for free carnitine. Two patients with carnitine palmityl transferase deficiency were similar to the other patients, but the carnitine-deficient patient lost excessive carnitine during fasting, probably secondary to an elevated acylcarnitine fraction in the blood.

AB - Free and total carnitine serum concentrations and urinary excretion were examined in patients with various neuromuscular diseases. On a measured, low carnitine diet and during fasting, the patients did not differ from controls. Carnitine excretion in patients (3.08 ± 1.87 μmol/kg/day) and controls (2.99 ± 1.12) exceeded carnitine intake (patients, 2.35 ± 0.94 μmol/kg/day; controls 1.33 ± 0.70). Because of heterogeneity in the patient population, carnitine excretion was assessed according to creatinine excretion, chosen as an indicator of muscle mass. Those patients with daily creatinine excretion < 1 g/day had significantly lower carnitine excretion (106 ± 47 versus 205 ± 95 μmol/day, p<0.05), and there was a positive correlation between creatinine excretion and carnitine excretion (r=0.82) and between muscle carnitine and carnitine excretion (r=0.67). Urinary clearances for acylcarnitine were 10 to 20 times higher than those for free carnitine. Two patients with carnitine palmityl transferase deficiency were similar to the other patients, but the carnitine-deficient patient lost excessive carnitine during fasting, probably secondary to an elevated acylcarnitine fraction in the blood.

UR - http://www.scopus.com/inward/record.url?scp=0019789326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019789326&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 2693

EP - 2698

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 12

ER -